Group 1: United Health - United Health is the worst performing stock in the Dow, down over 34% in 2025 due to rising medical costs and regulatory scrutiny over its Medicare Advantage business [56][57]. - The company faced challenges with medical cost management and leadership changes, which negatively impacted investor sentiment [60][61]. - Despite the difficulties, there are signs of a potential turnaround, with management guiding for EPS growth in 2026 [66][68]. Group 2: Salesforce - Salesforce shares are down more than 22% in 2025, facing concerns about AI's impact on its software and pressure from activist investors [81]. - The company has struggled to monetize AI effectively, leading to skepticism about its future growth prospects [82][84]. - Analysts suggest that Salesforce needs to improve its enterprise sales and product offerings to regain investor confidence [82][90]. Group 3: Proctor and Gamble - Proctor and Gamble is down about 14% this year, attributed to a deceleration in organic sales growth and cautious consumer spending [41][42]. - The company has seen a shift in consumer behavior, with a decline in premium product sales impacting overall performance [43][44]. - There is optimism for 2026, as the company may benefit from a normalization of sales growth trends and improved consumer sentiment [45][50]. Group 4: Nike - Nike is down about 11% this year, struggling with inventory issues and a prolonged turnaround process [8][9]. - The company has faced challenges in its lifestyle segment, losing market share due to changing consumer preferences [22][24]. - Analysts believe that Nike needs to demonstrate topline growth and regain consumer interest to improve its stock performance [21][23]. Group 5: Honeywell - Honeywell shares are down more than 6% in 2025, impacted by structural changes and a lack of exposure to high-growth sectors like AI [100][103]. - The company is undergoing a transformation to unlock value through spin-offs, but execution will be key to realizing this potential [101][104]. - Analysts expect Honeywell's aerospace business to show improvement in margins and growth in 2026 as contracts are reset [110][113].